{"id":"W4405309932","doi":"10.1111/bjh.19951","title":"Acalabrutinib in combination with rituximab and lenalidomide in patients with relapsed or refractory follicular lymphoma: Results of the phase 1b open‐label study ( <scp>ACE</scp> ‐ <scp>LY</scp> ‐003)","year":2024,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"AstraZeneca","keywords":"Lenalidomide; Rituximab; Follicular lymphoma; Medicine; Open label; Refractory (planetary science); Oncology; Internal medicine; Lymphoma; Phases of clinical research; Pharmacology; Multiple myeloma; Chemotherapy; Clinical trial; Biology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00206571,0.000290103,0.00138243,0.000500379,0.00009681207,0.0001358319,0.0005405111,0.0002421864,0.000005209356],"category_scores_gemma":[0.004262812,0.0001976588,0.00007019816,0.001142055,0.000455038,0.0004742286,0.00029691,0.0008351483,0.000003503824],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002095711,"about_ca_system_score_gemma":0.005051577,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009667882,"about_ca_topic_score_gemma":0.001354155,"domain_scores_codex":[0.9956281,0.0007498384,0.001440664,0.0005232788,0.001088786,0.0005694016],"domain_scores_gemma":[0.9964381,0.001717855,0.0006623595,0.0004226486,0.0005418007,0.0002171744],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"case_report","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.03844114,0.1643674,0.1172782,0.004576549,0.004020961,0.5565001,0.01958294,0.00006782196,0.0005652221,0.0006638672,0.04448038,0.04945536],"study_design_scores_gemma":[0.8399923,0.01346618,0.04899014,0.008257281,0.0004433782,0.07967683,0.004034224,0.0009893416,0.0009702831,0.0001751098,0.00287799,0.0001269156],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9942151,0.003035339,0.00002072497,0.0002520104,0.0001829864,0.001910357,0.00003568425,0.00001530771,0.0003325288],"genre_scores_gemma":[0.9986105,0.0003191532,0.0003566887,0.00009904367,0.00003244864,0.00003944199,0.00001794693,0.00006344519,0.0004613384],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.8015512,"threshold_uncertainty_score":0.8961281,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02246386859953324,"score_gpt":0.3153559056079925,"score_spread":0.2928920370084593,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}